Case Type: Mergers & Acquisitions

We are investigating Echelon Corporation (“Echelon” or the “Company”) (NasdaqGS: ELON) relating to the sale of the Company to Adesto Technologies Corporation (NasdaqCM: IOTS). Under the terms of the agreement, Echelon shareholders will receive $8.50 for each Echelon share of common stock they own.

We are investigating Cotiviti Holdings, Inc.(“Cotiviti” or the “Company”) (NYSE: COTV) relating to the proposed sale of the Company to Verscend Technologies, Inc. (“Verscend”). Under the terms of the agreement, Cotiviti shareholders are only anticipated to receive $44.75 in cash for each share of Cotiviti common stock that they own.

We are investigating the proposed sale of Perry Ellis International, Inc. (“Perry Ellis”) (PERY) to a privately held company Feldenkreis Holdings LLC, controlled by George Feldenkreis, Perry Ellis’ founder and board member. Under the terms of the proposed transaction, shareholders of Perry Ellis will receive only $27.50 in cash for each share of Perry Ellis … Read more

We are investigating Envision Healthcare Corporation (“Envision” or the “Company”) (NYSE: EVHC) relating to the sale of the Company to Kohlberg Kravis Roberts & Co. L.P. (“KKR”). Under the terms of the proposed transaction, Envision shareholders are only anticipated to receive $46.00 for each share of Envision common stock held.

We are investigating Foundation Medicine, Inc. (“FMI” or the “Company”) (FMI) relating to the proposed acquisition of the Company by Swiss healthcare company Roche Holding AG (“Roche”). As a result of the merger, FMI shareholders are only anticipated to receive $137.00 in cash for each FMI share they own.

We are investigating the sale of Juniper Pharmaceuticals, Inc. (“Juniper” or the “Company”) (JNP) to Catalent Inc. (CTLT) (“Catalent”). Under the terms of the transaction, Juniper shareholders will receive $11.50 for each share of Juniper common stock that they own.

We are investigating Express Scripts Holding Co. Acquisition (“Express Scripts” or the “Company”) (NasdaqGS: ESRX) relating to the sale of the Company to Cigna Corporation. (“Cigna”). Under the terms of the agreement, the Company’s shareholders will receive $48.75 in cash and 0.2434 of a share of the newly combined company for each Express Scripts share … Read more

We are investigating Stewart Information Services Corporation (“Stewart” or the “Company”) regarding its sale to Fidelity National Financial, Inc. (“FNF”) in a transaction valued at approximately $1.2 billion. Under the terms of the agreement, shareholders of Stewart will receive $50.00 for each share of Stewart common stock – the consideration will be paid in cash … Read more

We are investigating Xcerra Corporation (XCRA) (“Xcerra” or the “Company”) relating to the proposed buyout of Xcerra by Cohu, Inc. (“Cohu”). Under the terms of the agreement, Xcerra shareholders are anticipated to receive $9.00 and 0.2109 shares of Cohu common stock for each share of Xcerra common stock held.

We are investigating MB Financial, Inc. (“MB” or the “Company”) (NasdaqGS: MBFI) relating to the sale of the Company to Fifth Third Bancorp (“FTB”) (FITB). Under the terms of the Agreement, MB shareholders are only anticipated to 1.45 shares of FTB common stock and $5.54 in cash for each share of MB common stock that … Read more